Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Director/PDMR Shareholding

27 Mar 2019 07:00

RNS Number : 0951U
LiDCO Group Plc
27 March 2019
 

LiDCO Group Plc

("LiDCO" or the "Company")

 

Director/ PDMR Shareholding

LiDCO (AIM: LID), the hemodynamic monitoring company, announces the following share purchases made by employees on 26 March 2019.

· Mr Timothy Hall, Chief Financial Officer, purchased 100,000 ordinary shares of 0.5p nominal value ("Ordinary shares") at a price of 4.40p per Ordinary Share. Following the above transaction, Mr Hall's total beneficial holding is 100,000 Ordinary Shares, representing 0.041% of the Company's issued share capital.

· Mr Peter Grant, Chairman, purchased 200,000 ordinary shares of 0.5p nominal value ("Ordinary shares") at a price of 4.50p per Ordinary Share. Following the above transaction, Mr Grant's total beneficial holding is 700,000 Ordinary Shares, representing 0.287% of the Company's issued share capital.

· Mr Phil Cooper, Non-executive Director, purchased 100,000 ordinary shares of 0.5p nominal value ("Ordinary shares") at a price of 4.40p per Ordinary Share. Following the above transaction, Mr Cooper's total beneficial holding is 1,766.667 Ordinary Shares, representing 0.724% of the Company's issued share capital.

The below notification is made in accordance with the requirements of the EU Market Abuse Regulation.

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Timothy Hall

2.

Reason for the notification

a)

Position/status:

Chief Financial Officer

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

LiDCO Group Plc

b)

LEI:

213800PYQTIUV6HIYL36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 0.5 pence each

 

GB0030546849

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

4.40 pence per share

100,000

d)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

Total

4.40 pence per share

100,000

£4,400

e)

Date of the transaction:

26-03-2019

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Peter Grant

2.

Reason for the notification

a)

Position/status:

Chairman

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

LiDCO Group Plc

b)

LEI:

213800PYQTIUV6HIYL36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 0.5 pence each

 

GB0030546849

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

4.50 pence per share

200,000

d)

Aggregated information:

· Aggregated volume:

· Price:

Aggregate transaction as in 4 c) above

Price(s)

Volume(s)

Total

4.50 pence per share

200,000

£9.000

e)

Date of the transaction:

26-03-2019

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Phil Cooper

2.

Reason for the notification

a)

Position/status:

Non-executive Director

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

LiDCO Group Plc

b)

LEI:

213800PYQTIUV6HIYL36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 0.5 pence each

 

GB0030546849

b)

Nature of the transaction:

Purchase of Ordinary Shares

c)

Price(s) and volume(s):

Price(s)

Volume(s)

4.40 pence per share

100,000

d)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

Total

4.40 pence per share

100,000

£4,400

e)

Date of the transaction:

26-03-2019

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

 

 

For further information, please contact:

LiDCO Group Plc

www.lidco.com

Matt Sassone (CEO)

Tim Hall (CFO)

Tel: +44 (0)20 7749 1500

finnCap

Tel: +44 (0)20 7600 1658

Geoff Nash / Hannah Boros (Corporate Finance)

Andrew Burdis (ECM)

Walbrook PR Ltd

Tel: 020 7933 8780 or lidco@walbrookpr.com

Paul McManus (Media Relations)

Mob: 07876 741 001

Lianne Cawthorne (Media Relations)

Mob: 07584 391 303

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUNSWRKRAOUAR
Date   Source Headline
26th Jan 20064:38 pmPRNConvertible loan update
19th Jan 20067:00 amRNSProduct Development
19th Dec 20051:15 pmPRNResignation of a Director
8th Dec 20059:02 amPRNDirector Shareholding
18th Nov 20057:00 amRNSConversion of Loan
8th Nov 20057:01 amRNSPositive Study Data
3rd Nov 20057:00 amRNSUS Army Order
25th Oct 20057:01 amRNSClinical Advisory Board
18th Oct 20057:01 amRNSInterim Results
14th Oct 20051:39 pmPRNDirectorate Change
26th Sep 20059:11 amRNSNotice of Results
11th Aug 20057:02 amRNSUSD 2 Million Financing
14th Jul 20057:00 amRNSAdditional Listing
7th Jul 20057:01 amRNSNew Veterinary Application
23rd Jun 20054:00 pmRNSImpact of Review Paper
17th Jun 20057:00 amRNSBoard Appointment
16th Jun 20052:57 pmRNSAGM Statement
6th Jun 20052:38 pmPRNDirector Shareholding
1st Jun 20057:00 amRNSPositive Data
10th May 20052:20 pmPRNDirector Shareholding
9th May 20057:00 amRNSRegistration in Brazil
25th Apr 20057:00 amRNSAppointment of New Director
15th Apr 200511:46 amRNSDirector Shareholding
13th Apr 20057:00 amRNSDirector Share Options Award
7th Apr 20057:00 amRNSDirector Shareholding
30th Mar 20057:01 amRNSPreliminary Results
30th Mar 20057:01 amRNSProduct Approval in Denmark
24th Mar 20057:02 amRNSLaunch Of Software Upgrade
23rd Mar 200510:50 amPRNAdditional Listing
21st Mar 20057:02 amRNSSignificant Trial Results
15th Mar 20057:02 amRNSEuropean Approval
2nd Mar 20058:19 amRNSChange of Financial PR Agency
14th Feb 20057:00 amPRNMajor Clinical Trial
24th Jan 20053:25 pmPRNAdditional Listing
19th Jan 20054:16 pmPRNDirectorate Change
13th Jan 200511:28 amPRNAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.